QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Prostate cancer is an equal opportunity disease. It can strike any man at any time. And it struck Anthony. F Sansone, Sr. at age 64 in 1990. At the time, he was the CEO of an extremely successful commercial real…
Q: What procedures or techniques have been shown to have long-term relief or benefits for an enlarged prostate? Can you tell something about Prolieve Thermodilatation System and Green-Light-Photo Selective Vaporization? A: The standard initial treatments for an enlarged prostate gland…
(This article is technical in nature, but it shows how theoretical research, with support and focus, can quickly become helpful in clinical practice.) Brian Helfand, MD received the Astellas Award for the best abstract on prostate cancer at 2008 American…
Things can get so out of control if the first evidence is observed but not acted upon. I am not a fan of active monitoring or watchful waiting for men with a life expectancy of 10 years or more. There…
(This article is adapted for QUEST readers from an article by Stacy Loeb, MD* and William J. Catalona, MD: Prostate Specific Antigen in Clinical Practice.) For more than a decade, PSA (prostate specific antigen) has been approved by the US FDA both as…
OpEd piece published in the Washington Post, August 26, 2008 Numerous media reports followed a federal task force’s announcement this month that there is insufficient medical evidence to assess the risks and benefits of prostate cancer screening in men younger…
The place of diet, vitamins and supplements for prostate health is in limbo. New studies are showing that even foods we thought were helpful, such as those with lycopene, seem to have no benefit. And some of them, such as…
I am the Secretary of the URF Board and a patient of Dr. Catalona. He performed my radical prostatectomy in September 1997. I’ve written in Quest for over 5 years. I study, write, counsel, and lecture, but I am not…
I believe it is premature to comment on the potential usefulness of these new tests, PCA3 and EPCA-2, for early detection prostate cancer. Both tests have been developed by good scientists. The PCA3 test is already available through certain clinical…
Click here to read more Quest articles. | Print this page Dr. Catalona’s Recommendations for PSA Testing by William J. Catalona, MD My feeling is that testing should begin at age 40 but not because prostate cancer is a common…
"*" indicates required fields
